Advertisement
Screener

ENDRA LIFE SCIENCES INC. (NDRA) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

1.0 / 5 stars · 9/44 Roast Me

ENDRA LIFE SCIENCES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

ENDRA LIFE SCIENCES INC. (NDRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $0 for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2025-08-14

  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-06-30 was $0.00.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-03-31 was $0.00.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-12-31 was $0.00.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-09-30 was $0.00.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $0.00.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $0.00.
  • ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $0.00.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$0.00
10-Q · filed 2025-08-14
$0.00
derived: sum of 3 quarters · filed 2025-08-14
$0.00
derived: sum of 4 quarters · filed 2025-08-14
2025-03-31$0.00
10-Q · filed 2025-05-15
$0.00
derived: sum of 2 quarters · filed 2025-05-15
$0.00
derived: sum of 3 quarters · filed 2025-05-15
$0.00
derived: sum of 4 quarters · filed 2025-05-15
2024-12-31$0.00
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07
$0.00
derived: sum of 2 quarters · filed 2025-04-07
$0.00
derived: sum of 3 quarters · filed 2025-04-07
$0.00
10-K/A · filed 2025-04-07
2024-09-30$0.00
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-11-21
$0.00
derived: sum of 2 quarters · filed 2024-11-21
$0.00
10-Q/A · filed 2024-11-21
$0.00
derived: sum of 4 quarters · filed 2024-11-21
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$0.00
10-Q · filed 2024-08-14
$0.00
derived: sum of 3 quarters · filed 2024-08-14
$0.00
derived: sum of 4 quarters · filed 2024-08-14
2024-03-31$0.00
10-Q · filed 2024-05-14
$0.00
derived: sum of 2 quarters · filed 2024-05-14
$0.00
derived: sum of 3 quarters · filed 2024-05-14
$0.00
derived: sum of 4 quarters · filed 2024-05-14
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$0.00
derived: sum of 2 quarters · filed 2024-03-28
$0.00
derived: sum of 3 quarters · filed 2024-03-28
$0.00
10-K · filed 2024-03-28
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$0.00
derived: sum of 2 quarters · filed 2023-11-14
$0.00
10-Q · filed 2023-11-14
$0.00
derived: sum of 4 quarters · filed 2023-11-14
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$0.00
10-Q · filed 2023-08-14
$0.00
derived: sum of 3 quarters · filed 2023-08-14
$0.00
derived: sum of 4 quarters · filed 2023-08-14
2023-03-31$0.00
10-Q · filed 2023-05-15
$0.00
derived: sum of 2 quarters · filed 2023-05-15
$0.00
derived: sum of 3 quarters · filed 2023-05-15
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$0.00
derived: sum of 2 quarters · filed 2023-03-16
$0.00
10-K · filed 2023-03-16
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$0.00
10-Q · filed 2022-11-14
2022-06-30$0.00
10-Q · filed 2022-08-15
2021-03-31$285.49K
10-Q · filed 2021-05-17
2020-09-30$282.42K
10-Q · filed 2020-11-16
$685.37K
derived: sum of 2 quarters · filed 2020-11-16
$1.20M
10-Q · filed 2020-11-16
2020-06-30$402.95K
10-Q · filed 2020-08-14
$914.03K
10-Q · filed 2020-08-14
2020-03-31$511.08K
10-Q · filed 2021-05-17
2019-09-30$361.08K
10-Q · filed 2020-11-16
$718.03K
derived: sum of 2 quarters · filed 2020-11-16
$1.02M
10-Q · filed 2020-11-16
2019-06-30$356.95K
10-Q · filed 2020-08-14
$365.95K
10-Q · filed 2019-08-08
$659.22K
10-Q · filed 2020-08-14
2019-03-31$302.27K
10-Q · filed 2020-05-14
2018-09-30$300.17K
10-Q · filed 2019-11-13
$621.03K
derived: sum of 2 quarters · filed 2019-11-13
$940.39K
10-Q · filed 2019-11-13
2018-06-30$320.87K
10-Q · filed 2019-08-08
$640.22K
10-Q · filed 2019-08-08
2018-03-31$319.36K
10-Q · filed 2019-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRIDEX CORP (IRIX)United States$0.011B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B